Lv31
350 积分 2023-07-26 加入
PROTAC SERD vepdegestrant outperforms fulvestrant for advanced-stage ER+HER2− breast cancer harbouring acquired ESR1 mutations
1小时前
已完结
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER+/HER2- breast cancer
1个月前
已完结
Hormonal therapy for young-onset breast cancer: current understanding and lessons
1个月前
已关闭
Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group
1个月前
已完结
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts
1个月前
已完结
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts
1个月前
已完结
Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options
3个月前
已完结
Triple Negative Breast Cancer and Brain Metastases
3个月前
已完结
Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
5个月前
已完结
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis
6个月前
已完结
皖公网安备34019202002308
